Error: Could not add to watchlist. X

DelMar Pharmaceuticals Inc

+ Watchlist
BRRY:US
Ticker Change
BRRY:US has changed to a new ticker symbol
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
DelMar Pharmaceuticals, Inc. operates as a clinical and commercial stage drug development company with a focus on the treatment of cancer. The Company focuses on identifying clinical and commercial-stage compounds and establishing a scientific rationale for development in modern orphan drug indications. DelMar Pharmaceuticals serves customers worldwide.
ADDRESS
999 West Broadway
Suite 720
Vancouver, BC V5Z 1K5
Canada
PHONE
1-604-629-5989
  • Jeffrey Bacha
    Chairman/President/CEO/Co-Founder
  • Scott Praill
    Chief Financial Officer
  • Dennis M Brown
    Chief Scientific Ofcr/Co-Founder
Show More